Vyome Holdings (HIND) EBIT Margin (2015 - 2026)
Vyome Holdings (HIND) posted quarterly EBIT Margin of 3576.78% for Q1 2026, down 347657.0% year-over-year from N/an in Q1 2025, and up 3.52% quarter-over-quarter from 3707.35% in Q4 2025.
Vyome Holdings (HIND) EBIT Margin (2015 - 2026) Analysis & Trends
Vyome Holdings' EBIT Margin history runs 12 years deep, the most recent figure standing at 3576.78% for Q1 2026.
- In Q1 2026, EBIT Margin fell 347657.0% year-over-year to 3576.78%; the TTM figure through Mar 2026 stood at 1027.78% (down 90698.0% YoY), while the FY2025 annual figure was 3269.35%, down 287769.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 3576.78%, up from 3707.35% in the prior quarter.
- The five-year high for EBIT Margin was 95.61% in Q4 2023, with the low at 24761.92% in Q3 2025.
- The 5-year median for EBIT Margin is 319.64% (2022), against an average of 2097.81%.
- The sharpest annual moves came in 2023 and 2025: EBIT Margin jumped 44114 bps in 2023, then slumped 2442950 bps in 2025.
- Vyome Holdings' EBIT Margin stood at 536.75% in 2022, then soared by 82 bps to 95.61% in 2023, then tumbled by 336 bps to 416.76% in 2024, then tumbled by 790 bps to 3707.35% in 2025, then climbed by 4 bps to 3576.78% in 2026.
- Business Quant data shows HIND's EBIT Margin at 3576.78% in Q1 2026, 3707.35% in Q4 2025, and 24761.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | -3,200.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,200.02% |
| Mar 31, 2026 | -3,576.78% |
| Dec 31, 2025 | -3,707.35% |
| Sep 30, 2025 | -24,761.92% |
| Jun 30, 2025 | -222.38% |
| Mar 31, 2025 | -100.21% |
| Dec 31, 2024 | -416.76% |
| Sep 30, 2024 | -332.42% |
| Jun 30, 2024 | -104.53% |
| Mar 31, 2024 | -113.68% |
| Dec 31, 2023 | -95.61% |
| Sep 30, 2023 | -180.05% |
| Jun 30, 2023 | -176.40% |
| Mar 31, 2023 | -246.22% |
| Dec 31, 2022 | -536.75% |
| Sep 30, 2022 | -439.64% |
| Jun 30, 2022 | -319.64% |
| Mar 31, 2022 | -332.50% |
| Sep 30, 2021 | -388.86% |
| Jun 30, 2021 | -104.53% |